Importance of sex and gender factors for COVID-19 infection and hospitalisation: a sex-stratified analysis using machine learning in UK Biobank data.
COVID-19
health policy
risk management
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
18 05 2022
18 05 2022
Historique:
entrez:
18
5
2022
pubmed:
19
5
2022
medline:
21
5
2022
Statut:
epublish
Résumé
To examine sex and gender roles in COVID-19 test positivity and hospitalisation in sex-stratified predictive models using machine learning. Cross-sectional study. UK Biobank prospective cohort. Participants tested between 16 March 2020 and 18 May 2020 were analysed. The endpoints of the study were COVID-19 test positivity and hospitalisation. Forty-two individuals' demographics, psychosocial factors and comorbidities were used as likely determinants of outcomes. Gradient boosting machine was used for building prediction models. Of 4510 individuals tested (51.2% female, mean age=68.5±8.9 years), 29.4% tested positive. Males were more likely to be positive than females (31.6% vs 27.3%, p=0.001). In females, living in more deprived areas, lower income, increased low-density lipoprotein (LDL) to high-density lipoprotein (HDL) ratio, working night shifts and living with a greater number of family members were associated with a higher likelihood of COVID-19 positive test. While in males, greater body mass index and LDL to HDL ratio were the factors associated with a positive test. Older age and adverse cardiometabolic characteristics were the most prominent variables associated with hospitalisation of test-positive patients in both overall and sex-stratified models. High-risk jobs, crowded living arrangements and living in deprived areas were associated with increased COVID-19 infection in females, while high-risk cardiometabolic characteristics were more influential in males. Gender-related factors have a greater impact on females; hence, they should be considered in identifying priority groups for COVID-19 infection vaccination campaigns.
Identifiants
pubmed: 35584867
pii: bmjopen-2021-050450
doi: 10.1136/bmjopen-2021-050450
pmc: PMC9118360
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e050450Subventions
Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Investigateurs
Alexandra Kautzky-Willer
(A)
Karolina Kublickiene
(K)
Maria Trinidad Herrero
(MT)
Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Microb Genom. 2020 Jul;6(7):
pubmed: 32553051
Brain Behav Immun. 2020 Jul;87:184-187
pubmed: 32454138
Neuroimaging Clin N Am. 2020 Nov;30(4):433-445
pubmed: 33038994
BMC Bioinformatics. 2010 Feb 27;11:110
pubmed: 20187966
Diabetes Metab Res Rev. 2020 Mar 31;:e3319
pubmed: 32233013
Occup Environ Med. 2020 Dec 9;:
pubmed: 33298533
PLoS One. 2021 Apr 1;16(4):e0248602
pubmed: 33793566
Proc Int Conf Mach Learn. 2012 Dec 1;2012:349
pubmed: 24350304
Brain Behav Immun. 2020 Aug;88:44-49
pubmed: 32497776
Front Med (Lausanne). 2020 Jun 23;7:348
pubmed: 32671082
Prim Care Diabetes. 2020 Oct;14(5):566-567
pubmed: 32493608
CMAJ. 2020 Sep 8;192(36):E1041-E1045
pubmed: 32900766
PLoS One. 2020 Nov 17;15(11):e0241264
pubmed: 33201886
Neuroimaging Clin N Am. 2020 Nov;30(4):e17-e32
pubmed: 33039003
BMC Med. 2020 May 29;18(1):160
pubmed: 32466757
Nat Rev Immunol. 2020 Jul;20(7):442-447
pubmed: 32528136
EClinicalMedicine. 2020 Dec;29:100652
pubmed: 33283178
PLoS Med. 2015 Mar 31;12(3):e1001779
pubmed: 25826379
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):1315-1316
pubmed: 32755828
Wellcome Open Res. 2020 May 6;5:88
pubmed: 32613083
Expert Syst Appl. 2020 Dec 1;160:113661
pubmed: 32834556
J Gerontol A Biol Sci Med Sci. 2020 Oct 15;75(11):2224-2230
pubmed: 32687551
Biol Sex Differ. 2020 May 25;11(1):29
pubmed: 32450906
JMIR Public Health Surveill. 2021 Sep 30;7(9):e29544
pubmed: 34591027
Int J Equity Health. 2020 Jul 6;19(1):114
pubmed: 32631328
Mayo Clin Proc. 2020 Oct;95(10):2189-2203
pubmed: 33012349
Int J Equity Health. 2009 May 06;8:14
pubmed: 19419579
J Clin Epidemiol. 2021 Jan;129:191-197
pubmed: 32980428